iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in iTeos Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 151
- +14 vs. Q2 2024
- Shares held
- 36.6M
- +4.14M (+12.8%) vs. Q2 2024
- Total value
- $373.3M
- −$108.1M (−22.5%) vs. Q2 2024
- New holders
- 26
- 56 more added
- Sold out
- 12
- 43 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna Portfolio Strategies, LLC | 62,062 | $633.7K | 0.04% | −39,713−39.0% | Reduced |
| American Century Companies Inc | 63,210 | $645.4K | 0.00% | +16,888+36.5% | Added |
| Bridgeway Capital Management, LLC | 65,767 | $671.5K | 0.01% | +3,350+5.4% | Added |
| Empowered Funds, LLC | 65,767 | $671.5K | 0.01% | +3,350+5.4% | Added |
| UBS Oconnor LLC | 65,940 | $673.2K | 0.02% | +30,617+86.7% | Added |
| Panagora Asset Management Inc | 67,723 | $691.5K | 0.00% | −63,830−48.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 68,243 | $696.8K | 0.01% | +68,243 | New |
| Bank of America Corp | 76,766 | $783.8K | 0.00% | −7,270−8.7% | Reduced |
| Ikarian Capital, LLC | 78,574 | $802.2K | 0.25% | 00.0% | Unchanged |
| Invesco Ltd. | 84,355 | $861.3K | 0.00% | −231−0.3% | Reduced |
| Victory Capital Management Inc | 95,240 | $972.4K | 0.00% | −15,149−13.7% | Reduced |
| Bank of New York Mellon Corp | 103,165 | $1.05M | 0.00% | −18,085−14.9% | Reduced |
| Wellington Management Group LLP | 105,769 | $1.08M | 0.00% | +18,255+20.9% | Added |
| Barclays PLC | 113,211 | $1.16M | 0.00% | −9,064−7.4% | Reduced |
| Two Sigma Investments, LP | 122,697 | $1.25M | 0.00% | +35,077+40.0% | Added |
| D. E. Shaw & Co., Inc. | 125,761 | $1.28M | 0.00% | −93,562−42.7% | Reduced |
| Cubist Systematic Strategies, LLC | 132,364 | $1.35M | 0.02% | +132,364 | New |
| Eagle Asset Management Inc | 151,649 | $1.41M | 0.01% | −12,583−7.7% | Reduced |
| Kennedy Capital Management, Inc. | 155,435 | $1.59M | 0.04% | +5,185+3.5% | Added |
| Nuveen Asset Management, LLC | 157,331 | $1.61M | 0.00% | −200,840−56.1% | Reduced |
| DAFNA Capital Management LLC | 161,584 | $1.65M | 0.39% | +17,224+11.9% | Added |
| Clearline Capital LP | 167,417 | $1.71M | 0.15% | +10,523+6.7% | Added |
| Readystate Asset Management LP | 169,819 | $1.73M | 0.09% | +83,700+97.2% | Added |
| Qube Research & Technologies Ltd | 175,591 | $1.79M | 0.00% | +136,987+354.9% | Added |
| Saturn V Capital Management LLC | 195,704 | $2.00M | 0.71% | −171,725−46.7% | Reduced |
| Jacobs Levy Equity Management, Inc | 205,863 | $2.10M | 0.01% | +29,549+16.8% | Added |
| Charles Schwab Investment Management Inc | 222,135 | $2.27M | 0.00% | +8,397+3.9% | Added |
| Northern Trust Corp | 251,856 | $2.57M | 0.00% | +10,301+4.3% | Added |
| Prudential Financial Inc | 253,291 | $2.59M | 0.00% | +22,800+9.9% | Added |
| Algert Global LLC | 256,139 | $2.62M | 0.07% | +122,730+92.0% | Added |
| ADAR1 Capital Management, LLC | 376,737 | $3.85M | 0.64% | +316,737+527.9% | Added |
| JPMorgan Chase & Co | 467,319 | $4.77M | 0.00% | +5,368+1.2% | Added |
| Morgan Stanley | 501,366 | $5.12M | 0.00% | −587,933−54.0% | Reduced |
| K2 Principal Fund, L.P. | 534,951 | $5.46M | 0.91% | +277,871+108.1% | Added |
| Renaissance Technologies LLC | 536,400 | $5.48M | 0.01% | −23,200−4.1% | Reduced |
| Geode Capital Management, LLC | 640,350 | $6.54M | 0.00% | +20,092+3.2% | Added |
| Candriam Luxembourg S.C.A. | 769,213 | $7.85M | 0.05% | +259,910+51.0% | Added |
| Goldman Sachs Group Inc | 913,013 | $9.32M | 0.00% | +180,741+24.7% | Added |
| Vestal Point Capital, LP | 1,025,000 | $10.5M | 0.83% | −725,000−41.4% | Reduced |
| Dimensional Fund Advisors LP | 1,046,200 | $10.7M | 0.00% | +137,871+15.2% | Added |
| State Street Corp | 1,175,353 | $12.0M | 0.00% | +211,452+21.9% | Added |
| Citadel Advisors LLC | 1,236,259 | $12.6M | 0.01% | +538,927+77.3% | Added |
| 683 Capital Management, LLC | 1,570,288 | $16.0M | 1.63% | +455,288+40.8% | Added |
| EcoR1 Capital, LLC | 1,608,616 | $16.4M | 0.56% | −1,641,219−50.5% | Reduced |
| Vanguard Group Inc | 1,656,810 | $16.9M | 0.00% | −393,196−19.2% | Reduced |
| MPM Oncology Impact Management LP | 1,745,943 | $17.8M | 2.67% | 00.0% | Unchanged |
| Tang Capital Management LLC | 2,407,800 | $24.6M | 1.76% | +2,407,800 | New |
| MPM Asset Management LLC | 2,738,785 | $28.0M | 19.25% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,946,915 | $30.1M | 1.48% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,184,711 | $32.5M | 0.37% | −332,548−9.5% | Reduced |
| BlackRock, Inc. | 3,882,549 | $39.6M | 0.00% | +3,882,549 | New |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −723,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −37,673−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −25,398−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −23,439−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −20,814−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −16,485−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −16,083−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −13,119−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −3,776−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −205−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Sofos Investments, Inc. | – | – | – | – | Not filed |